Upcoming Webinars

https://biopharmawebinars.com/webinars/intelligent-biomanufacturing-systems-from-design-to-control-in-industry-4-0/

Intelligent Biomanufacturing Systems: From Design to Control in Industry 4.0

Presented by Irina Ramos, PhD, Senior Distinguished Scientist, CMC and Innovation Lead at J&J Innovative Medicine, Dr. Tiago Matos, Assistant Professor Tecnico, University of Lisbon
05th November 2026

https://biopharmawebinars.com/webinars/endotoxin-testing-of-pharmaceutical-products-using-synthetic-reagents/

Endotoxin Testing of Pharmaceutical Products using Synthetic Reagents

Presented by Poppy Cliffe, Senior Scientist in Microbiology, Global Product Development at AstraZeneca, Nicola Reid, Director, Portfolio Product Manager, Pyrogen & Endotoxin Detection, Charles River
06th November 2026

https://biopharmawebinars.com/webinars/enhancing-plasmid-dna-quality-through-robust-topology-measurement/

Enhancing Plasmid DNA Quality Through Robust Topology Measurement

Presented by Dr. Anthony Blaszczyk, Principal Scientist in the Global Biologics Department at U.S. Pharmacopeia, Mateusz Imiolek, Principal Scientist at Waters
09th November 2026

https://biopharmawebinars.com/webinars/interpreting-the-new-us-pharmacopoeia-guidance-for-sterility-microbial-testing-in-cell-therapy/

Roundtable Discussion: Interpreting the New US Pharmacopoeia Guidance for Sterility & Microbial Testing in Cell Therapy

Presented by Dr. Huiping Tu, Senior Principal Scientist, Microbiology, Global Biologics United States Pharmacopeia (USP), Dr David Roesti, Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Dr. Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Dr. Lori Daane, Founder and Principal Scientist at Macro Scope BioConsulting, Stephane Dubreux, Pharm.D. / MBA, Scientific Affairs Director for Pharma Quality Control at bioMérieux
11th November 2026

 

On Demand Webinars

https://biopharmawebinars.com/webinars/particulate-control-in-parenteral-drug-delivery-devices/

Particulate Control in Parenteral Drug Delivery Devices

Presented by Rong Guo, Senior Reviewer at CDRH/FDA, Dr. Bettine Boltres, Director Scientific Affairs, Integrated Systems at West, John Rech, Technology Manager – Particle – Analytical Services at West
30th October 2026

https://biopharmawebinars.com/webinars/navigating-particulate-matter-analysis-in-biologic-drug-products-a-critical-evaluation-of-flow-imaging-and-light-obscuration-for-product-quality-assessment/

Navigating Particulate Matter Analysis in Biologic Drug Products: A Critical Evaluation of Flow Imaging and Light Obscuration for Product Quality Assessment

Presented by Ashwinkumar Bhirde, PhD. FDA/CDER/OPQ, Senior Pharmaceutical Scientist, Louise Brogan, PhD, Marketing Director, Yokogawa Fluid Imaging Technologies and Amber Raines, Ph.D., Senior Director of Client Project Management at Coriolis Pharma, U.S.
27th October 2026

https://biopharmawebinars.com/webinars/assessing-the-use-of-solid-phase-cytometry-for-rapid-bioburden-testing-2/

Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing

Presented by Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca
22nd October 2026

https://biopharmawebinars.com/webinars/managing-analytical-procedure-lifecycles-resolving-longstanding-mass-spectrometry-challenges-for-emerging-nitrosamine-and-ndsri-impurities/

Managing Analytical Procedure Lifecycles: Resolving Longstanding Mass Spectrometry Challenges for Emerging Nitrosamine and NDSRI Impurities

Presented by Jinhui Zhang, Chemist at FDA/CDER, Andrew Teasdale, Principal Consultant at Nelson Labs
15th October 2026